This site is intended for healthcare professionals only
LoginRegister

Nephrology Dialogues

High dose Anifrolumab Effective for Treatment of Lupus Nephritis

High dose Anifrolumab Effective for Treatment of Lupus Nephritis

A two-year phase II TULIP-LN trial (NCT02547922) demonstrated the safety and efficacy of anifrolumab in treating active lupus nephritis, with the...
View All

Latest News and Guidelines

High Bleeding Risk with 5mg Apixaban among patients with Atrial Fibrillation with CKD compared to lower dose

High Bleeding Risk with 5mg Apixaban among patients with Atrial Fibrillation with CKD compared to...

Intradialytic Exercise Improves Health Outcomes in Hemodialysis Patients

Intradialytic Exercise Improves Health Outcomes in Hemodialysis Patients

FDA Approves Empagliflozin for CKD treatment, regardless of diabetes status

FDA Approves Empagliflozin for CKD treatment, regardless of diabetes status

Eculizumab Mitigates Long-Term Kidney Damage in Pediatric Patients

Eculizumab Mitigates Long-Term Kidney Damage in Pediatric Patients

Use of oldest PRBC for transfusion after kidney transplant associated with better outcomes: JAMA

Use of oldest PRBC for transfusion after kidney transplant associated with better outcomes: JAMA

D-Mannose prophylaxis not effective for preventing UTI after kidney transplantation: Manotras Study

D-Mannose prophylaxis not effective for preventing UTI after kidney transplantation: Manotras Study

View All
X